Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer
Authors:
- Susanne K. KjaerSKSusanne K. Kjaer
- Birthe L. ThomsenBTBirthe L. Thomsen
- Claus HøgdallCHClaus Høgdall
- Lise ChristensenLCLise Christensen
- Estrid HøgdallEstrid Høgdall
- Johannes E. BockJBJohannes E. Bock
- Jan BlaakaerJBJan Blaakaer
- 8 November 2004
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 164 (20) , 2253-2259
Abstract
Research from JAMA Internal Medicine — Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian CancerKeywords
This publication has 12 references indexed in Scilit:
- Hormone Replacement Therapy Formulations and Risk of Epithelial Ovarian CarcinomaGynecologic Oncology, 2002
- Menopausal Hormone Replacement Therapy and Risk of Ovarian CancerJAMA, 2002
- Hormone Replacement Therapy and the Risk of Invasive Epithelial Ovarian Cancer in Swedish WomenJNCI: Journal of the National Cancer Institute, 2002
- Estrogen Replacement Therapy and Ovarian Cancer Mortality in a Large Prospective Study of US WomenJAMA, 2001
- A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancerJournal of Clinical Epidemiology, 2000
- Hormone replacement therapy and risk of epithelial ovarian cancerBritish Journal of Cancer, 1999
- Estrogen Replacement Therapy and Risk of Epithelial Ovarian CancerGynecologic Oncology, 1996
- Pathology of Epithelial Ovarian TumorsClinical Obstetrics and Gynecology, 1994
- NONCONTRACEPTIVE ESTROGEN USE AND EPITHELIAL OVARIAN CANCERAmerican Journal of Epidemiology, 1989
- Reliability of Women's Histories of Climacteric Oestrogen Treatment Assessed by Prescription FormsInternational Journal of Epidemiology, 1987